Novartis Venture Funds

Industry:

6630 Fund management

Address:

Novartis International AG WSJ-200.220 P.O. Box

4002 Basel , Basel-Stadt

Switzerland

See map: Google Maps, map.search.ch

Basel-Stadt CH

Phone:

+41 (61) 324-6210

Investment lists:

corporate venturing

Official name:

Novartis International AG

Registration country:

Switzerland

ISIC Code:

6630

Company type:

The corporate venturing arm of Novartis.

Overview:

PSEPS

Web site:

http://www.venturefund.novartis.com

Selected investments

Displaying 1 - 20 of 49

	Profile	Country	Industry	Funding	Date
Alnylam Pharmaceuticals Inc		United States	2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products	N/A
Anchor Therapeutics Inc		United States	7210 Research and experimental development on natural sciences and engineering	USD Series B	Aug 2010
Ascent Therapeutics Inc		United States	2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products	USD Series A	Nov 2007
Autonomic Technologies Inc		United States	2660 Manufacture of irradiation, electromedical and electrotherapeutic equipment	N/A
Avila Therapeutics Inc	A biotechnology company, pioneering a method to discover and develop new small-molecule medicines that achieve 'protein silencing'.	United States	7210 Research and experimental development on natural sciences and engineering	N/A
Biofisica Inc	Wound care company.	United States	2660 Manufacture of irradiation, electromedical and electrotherapeutic equipment	Series A	Oct 2006
Catalyst Biosciences Inc	Developer of catalytic biopharmaceutical products based on engineered human proteases.	United States	7210 Research and experimental development on natural sciences and engineering	USD Series C	Dec 2008
Catalyst Biosciences Inc	Developer of catalytic biopharmaceutical products based on engineered human proteases.	United States	7210 Research and experimental development on natural sciences and engineering	USD Series B	Feb 2006
Catalyst Biosciences Inc	Developer of catalytic biopharmaceutical products based on engineered human proteases.	United States	7210 Research and experimental development on natural sciences and engineering	USD Series A	Oct 2004
Celladon Corp		United States	7210 Research and experimental development on natural sciences and engineering	N/A
Cequent Pharmaceuticals		United States	7210 Research and experimental development on natural sciences and engineering	USD Series A	Jun 2007
ESBATech AG	Switzerland based Biomedical Research Unit of Alcon	Switzerland	7210 Research and experimental development on natural sciences and engineering	CHF Series B	Aug 2008
ESBATech AG	Switzerland based Biomedical Research Unit of Alcon	Switzerland	7210 Research and experimental development on natural sciences and engineering	CHF Series B	Aug 2006
ESBATech AG	Switzerland based Biomedical Research Unit of Alcon	Switzerland	7210 Research and experimental development on natural sciences and engineering	CHF	May 2002
FoldRx Pharmaceuticals Inc		United States	2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products	N/A	Jun 2010
Forma Therapeutics Inc		United States	7210 Research and experimental development on natural sciences and engineering	N/A
Heptares Therapeutics Ltd		United Kingdom		GBP Series A	Feb 2009
Intradigm Corp		United States	7210 Research and experimental development on natural sciences and engineering	USD Series B	Jan 2009
Intradigm Corp		United States	7210 Research and experimental development on natural sciences and engineering	Series A	Nov 2006
IRX Therapeutics Inc		United States	7210 Research and experimental development on natural sciences and engineering	N/A

Pages

Current employees

Employee		Job title	Office
	Florent Gros	Managing Director	Basel
	Rudolf Gygax	Managing Director	Basel

Top co-investors

Co-investors that have participated in the same funding rounds.

Displaying 1 - 25 of 56

	Profile	Country	Deals
Alexandria Real Estate Equities Inc		United States	3
Athenian Venture Partners		United States	3
Lilly Ventures		United States	3
Novartis Services Inc		United States	3
Triathlon Medical Ventures LLC		United States	3
Apple Tree Partners		United States	2
BioVentures Investors LLC		United States	2
CHL Medical Partners		United States	2
Elm Street Ventures		United States	2
HBM BioVentures AG		Switzerland	2
Kearny Venture Partners		United States	2
Mitsui & Co Global Investment Inc		United States	2
New Leaf Venture Partners		United States	2
Roche Venture Fund	The corporate venture fund of the healthcare company Roche	Switzerland	2
Sigvion Capital		United States	2
Venture Investors LLC		United States	2
Aberdare Ventures		United States	1
Affinity Capital Management		United States	1
AgeChem Fund LP		Canada	1
Aisling Capital		United States	1
Amgen Ventures			1
Baxter Ventures			1
BB Biotech Ventures		Switzerland	1
Bessemer Venture Partners	Early stage venture capital firm.	United States	1
Biogen Idec Inc		United States	1